Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study

November 14, 2013 7:30 am | by Business Wire | News | Comments

Svelte® Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study...

ReliantHeart expands CE Mark for HeartAssist5 ventricular assist device

November 13, 2013 1:29 pm | by Mass Device | News | Comments

ReliantHeart this week won expanded CE Mark approval in Europe for its ventricular assist device, which the company calls "the only remotely monitored VAD in the world." The HeartAssist5 system originally won European approval under MicroMed...

Danish Researchers Predict Risk of Valvular Heart Disease

November 13, 2013 10:38 am | by University of Copenhagen | News | Comments

Researchers at the University of Copenhagen, Rigshospitalet and Herlev Hospital have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular...

Advertisement

Volcano Corporation Announces First Commercial Implantations of Crux Vena Cava Filter

November 13, 2013 9:01 am | by The Associated Press | News | Comments

Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced the commercial release and initial...  

Healthcare Reform Driving Out Cost at All Levels

November 12, 2013 3:24 pm | by Tim Taylor, Director of Sales-Medical, XP Power | Xp Power | Blogs | Comments

The reform of healthcare provision and the way it is funded has become a very emotive issue. Whatever your thoughts and viewpoints on the topic of the Affordable Care Act, one of the underlying priorities of this reform is to drive cost out...

Biosensors lowers guidance on weakness in stent market

November 12, 2013 1:20 pm | by Mass Device | News | Comments

Singapore-based stent-maker Biosensors International lowered its full-year sales outlook, reporting softness in the stent market, pricing pressures and delays in anticipated royalty growth in Japan. The company's profits sank by 60% during the...

From Knee to Neuron, Offspring of 3D Printers Multiply

November 12, 2013 12:41 pm | by Eric Gershon, Yale | News | Comments

Yale neuroscientist Gordon Shepherd has studied neurons for decades. But until recently he’d never had a neuron he could grasp with his own two hands: Neurons are much too small. Now he’s got his very own 3D neuron in all its spidery glory...

1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana

November 12, 2013 4:15 am | by PR Newswire | News | Comments

An Indiana man has become the 1,200th person in the world to be implanted with the SynCardia temporary Total Artificial Heart. Patrick O'Hara is the first person in Indiana to receive the life-saving device and the first Hoosier to be discharged...

Advertisement

Meeting Notice: December 11, 2013 Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

November 12, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On December 11, 2013, the committee will discuss, make recommendations, and vote on information related to the premarket approval application regarding the Boston Scientific WATCHMAN Left Atrial Appendage (LAA) Closure Technology. The WATCHMAN...

Snap to Attention: Polymers that React and Move to Light

November 11, 2013 4:39 pm | by University of Pittsburgh | News | Comments

Microvehicles and other devices that can change shape or move with no power source other than a beam of light may be possible through research led by the University of Pittsburgh. The researchers are investigating polymers that "snap" when...

Official Roster of Teams Announced in the $10 Million Qualcomm Tricorder XPRIZE

November 11, 2013 10:21 am | by XPRIZE | News | Comments

XPRIZE has announced the 34 registered teams competing for the Qualcomm Tricorder XPRIZE, a 3.5-year global competition sponsored by the Qualcomm Foundation that will award $10 million to teams that develop a consumer-friendly, mobile... 

ITGI Signs Strategic Cooperation Agreement with Vascular Solutions to Commercialize ITGI's Coronary Covered Stent in the U.S. Market

November 11, 2013 9:00 am | by Business Wire | News | Comments

ITGI (TASE:ITGI) announces today the initiation of its activity in the U.S. market. The company has signed a strategic cooperation agreement with U.S.-based Vascular Solutions, Inc. (NASDAQ:VASC), an international leader in the interventional...

Possible Bloodstream Contamination Leads to Class I Recall

November 8, 2013 4:03 pm | by David Mantey, Executive Editor | News | Comments

On September 23, 2013 Montreal, Canada-based Baylis Medical Company sent an urgent device recall letter to its customers. As reported by the U.S. Food and Drug Administration (FDA) on November 6, 2013, the Class I recall affects 1,035...

Advertisement

Human Waste Powers Artificial Hearts in Robots

November 8, 2013 3:53 pm | by Michael Bishop, Institute of Physics | News | Comments

A new device capable of pumping human waste into the "engine room" of a self-sustaining robot has been created by a group of researchers from Bristol. Modelled on the human heart, the artificial device ...        

Samsung Aims to Be Top Medical Device Maker

November 6, 2013 10:38 am | by Youkyung Lee, AP Technology Writer | News | Comments

Samsung wants to be the top medical device maker through acquiring companies and developing its own technologies. In the last three years, Samsung spent $1 billion to buy 14 companies in medical equipment, mobile software and services ...

Innovative Touch-Activated Phlebotomy Blood Collection & Testing System

November 6, 2013 10:27 am | by Seventh Sense Biosystems | News | Comments

Seventh Sense Biosystems has announced that it has obtained CE Mark approval for its Touch Activated Phlebotomy (TAP™) platform for blood collection and testing. Studies show that a positive patient experience is closely linked to compliance with ...

CE Mark for PK Papyrus Covered Stents

November 5, 2013 4:17 pm | by Biotronik | News | Comments

The single-layer covered stent design, with its 90μm polyurethane membrane, further enables a 24% lower crossing profile, combining high flexibility and a low crossing profile for exceptional deliverability while sealing defects in ...  

AngioDynamics Achieves CE Approval for AngioVac

November 1, 2013 2:18 pm | by Globe Newswire | News | Comments

AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced EU CE Mark approval for its AngioVac venous drainage cannula and...

Boston Scientific Completes Acquisition of Bard Electrophysiology

November 1, 2013 12:07 pm | by PR Newswire | News | Comments

Boston Scientific Corporation closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. The completion of this transaction advances Boston Scientific's ability to more comprehensively...

Mobile + Apps = Healthcare Future

October 31, 2013 3:57 pm | by IMS Health | News | Comments

This infographic offers highlights of a study that looks at the current state of consumer mobile apps in healthcare—the range of apps available and their functionality, the barriers that exist to their broad use, and what is needed to move apps to a more significant role in improved and cost-effective healthcare systems.

Svelte Medical Systems raises $22 million

October 31, 2013 3:24 pm | by Mass Device | News | Comments

Svelte Medical Systems said it raised $22 million to complete a clinical trial of its coronary stent platforms, taking its total raise to $65 million since 2007. Venture capital shops New Science Ventures and CNF Investments led the latest round for...

Medtronic Renal Denervation Device Offers Significant Drops in Blood Pressure After Treatment

October 31, 2013 2:39 pm | by Medtronic | News | Comments

Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running randomized, controlled clinical trial of renal denervation, which continue to demonstrate results consistent with data reported previously at six, 12...

Abiomed surges on Medicare move not to change reimbursement rate

October 31, 2013 1:20 pm | by Mass Device | News | Comments

Shares of Abiomed surged nearly 10% today after news broke that Medicare will maintain the reimbursement rate for its flagship Impella heart pump. The Danvers, Mass.-based medical device company's stock took a roller-coaster ride last month...

Study Compares Provisional and Two-Stent Strategies for Coronary Bifurcation Lesions

October 31, 2013 10:15 am | by Cardiovascular Research Foundation | News | Comments

A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the...

A Mimic of 'Good Cholesterol' Could Someday Treat Cardiovascular Disease

October 31, 2013 10:12 am | by American Chemical Society | News | Comments

A new type of "good cholesterol," made in the lab, could one day deliver drugs to where they are needed in the body to treat disease or be used in medical imaging, according to scientists. Their report on the high-density lipoprotein (HDL) mimic...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading